miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells

Experimental and Therapeutic Medicine

Volumn 8, Issue 2, 2014, Pages 591-594

  Zhang, Jing ^a   Wang, Lu ^a   Li, Baoli ^a   Huo, Manpeng ^a   Mu, Mingtao ^a   Liu, Junjun ^a   Han, Jiming ^a  

^a YAN'AN UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Cyclin dependent kinase 6; Eukaryotic expression vector; miRNA 145

Indexed keywords

CYCLIN DEPENDENT KINASE 6; MICRORNA 145;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; MTT ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

EID: 84902602282     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1765     Document Type: Article

References (18)

1. Ni J, Gao S, Cui LY and Li SW: Intracranial arterial occlusive lesion in patients with Graves' disease. Chin Med Sci J 21: 140-144, 2006.
2. Waggoner SE: Cervical cancer. Lancet 361: 2217-2225, 2003.
3. Peiretti M, Zapardiel I, Zanagnolo V, et al: Management of recurrent cervical cancer: a review of the literature. Surg Oncol 21: e59-e66, 2012.
4. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Qiang R, Wang F, Shi LY, et al: Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 43: 632-641, 2011.
6. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PloS One 6: e28423, 2011.
7. Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
8. Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
9. Li T, Li D, Sha J, Sun P and Huang Y: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285, 2009.
10. Cai J, Fang L, Huang Y, et al: miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res 73: 5402-5415, 2013.
11. Roy S, Yu Y, Padhye SB, et al: Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One 8: e68543, 2013.
12. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
13. Mattick JS and Makunin IV: Non-coding RNA. Hum Mol Genet 15: R17-R29, 2006.
14. Xiao B, Guo J, Miao Y, et al: Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400: 97-102, 2009.
15. Gao W, Shen H, Liu L, Xu J, Xu J and Shu Y: MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 137: 557-566, 2011.
16. Sun L, Yao Y, Liu B, et al: MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31: 432-445, 2012.
17. Sridhar J, Akula N and Pattabiraman N: Selectivity and potency of cyclin-dependent kinase inhibitors. AAPS J 8: E204-E221, 2006.
18. Sheedy FJ, Palsson-Mcdermott E, Hennessy EJ, et al: Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141-147, 2010.